Utah Medical Products, Inc. (UTMD) Position Reduced by Clean Yield Group
Clean Yield Group lowered its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 1.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,291 shares of the medical instruments supplier’s stock after selling 858 shares during the period. Utah Medical Products accounts for about 1.5% of Clean Yield Group’s holdings, making the stock its 20th biggest position. Clean Yield Group owned 1.27% of Utah Medical Products worth $3,849,000 at the end of the most recent reporting period.
Other large investors have also recently modified their holdings of the company. Acrospire Investment Management LLC grew its stake in Utah Medical Products by 339.1% during the second quarter. Acrospire Investment Management LLC now owns 1,919 shares of the medical instruments supplier’s stock valued at $139,000 after acquiring an additional 1,482 shares in the last quarter. Prudential Financial Inc. purchased a new position in Utah Medical Products during the second quarter valued at approximately $233,000. The Manufacturers Life Insurance Company grew its stake in Utah Medical Products by 15.4% during the second quarter. The Manufacturers Life Insurance Company now owns 3,355 shares of the medical instruments supplier’s stock valued at $242,000 after acquiring an additional 448 shares in the last quarter. OxFORD Asset Management LLP purchased a new position in Utah Medical Products during the second quarter valued at approximately $267,000. Finally, Citigroup Inc. grew its stake in Utah Medical Products by 16.9% during the second quarter. Citigroup Inc. now owns 3,750 shares of the medical instruments supplier’s stock valued at $272,000 after acquiring an additional 541 shares in the last quarter. 66.67% of the stock is owned by institutional investors.
Separately, BidaskClub raised shares of Utah Medical Products from a “hold” rating to a “buy” rating in a research note on Wednesday, December 6th.
Utah Medical Products (NASDAQ:UTMD) last announced its earnings results on Tuesday, October 24th. The medical instruments supplier reported $0.97 earnings per share (EPS) for the quarter. Utah Medical Products had a net margin of 34.31% and a return on equity of 18.31%.
The business also recently announced a quarterly dividend, which was paid on Wednesday, January 3rd. Shareholders of record on Friday, December 15th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Thursday, December 14th. This is a positive change from Utah Medical Products’s previous quarterly dividend of $0.27. This represents a $1.08 annualized dividend and a yield of 1.30%. Utah Medical Products’s payout ratio is presently 29.35%.
About Utah Medical Products
Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.
Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD).
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.